Three new bluetongue cases confirmed in the UK

Published 2024년 9월 16일

Tridge summary

Three new cases of bluetongue in cattle have been confirmed in Essex, England, increasing the total affected premises to 56. The Department for Environment, Food and Rural Affairs (Defra) has approved the use of three emergency vaccines for the bluetongue variant 3 (BTV-3) in the UK. BTV-3 was first detected in the UK on November 10, 2023, and has since spread from the Netherlands to several European countries. The disease causes symptoms like fever, lesions, and redness in animals, but it does not affect humans and does not compromise food security. The movement of animals and germinal products out of the control zone is prohibited, with certain exceptions. The import of livestock from Great Britain to Ireland remains suspended due to the disease.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Three new cases of bluetongue have been confirmed in cattle in Essex in England, bringing the total number of affected premises to 56 as of yesterday (September 15). These cases have been identified through surveillance testing in the restricted zone and add to the incidences identified on September 14 – two of which were located in Essex, while a third was accounted for in the East Riding of Yorkshire, which is now deemed a temporary control zone (TCZ). The Department for Environment, Food and Rural Affairs (Defra) secretary of state has permitted the use of three new unauthorised vaccines in the UK for bluetongue variant 3 (BTV-3), which is currently the most active of the virus strains. Vaccination for BTV-3 is not available for commercial sale and is only sanctioned for use in emergency circumstances, as EU-wide authorisation is still pending. BTV-3 was first reported in September 2023 in the Netherlands and has since spread to other countries including Belgium; German; ...
Source: AgriLand

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.